{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:05:53Z","timestamp":1761894353208,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.healun.2006.03.002","type":"journal-article","created":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T00:01:27Z","timestamp":1152230487000},"page":"805-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Can Donors With Prior Hepatitis Be Safely Used for Heart Transplantation?"],"prefix":"10.1016","volume":"25","author":[{"given":"Steven D.","family":"Mawhorter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin K.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2006.03.002_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1034\/j.1600-6143.2002.20804.x","article-title":"Report of the Crystal City meeting to maximize the use of donor organs recovered from the cadaver donor","volume":"2","author":"Rosengard","year":"2002","journal-title":"Am J Transplant"},{"unstructured":"http:\/\/www.osotc.org\/st_wait.htm. Accessed Sept 29, 2004.","key":"10.1016\/j.healun.2006.03.002_bib2"},{"key":"10.1016\/j.healun.2006.03.002_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jmv.2187","article-title":"Risk factors and mechanism of transplacental transmission of hepatitis B virus","volume":"67","author":"Xu","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.healun.2006.03.002_bib4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/art.1780401113","article-title":"Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia","volume":"40","author":"Agnello","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.healun.2006.03.002_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1034\/j.1600-6143.2001.10214.x","article-title":"Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor","volume":"1","author":"Chung","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/314000","article-title":"Cadaver donor screening for infectious agents in solid organ transplantation","volume":"31","author":"Delmonico","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2006.03.002_bib7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/hep.1840080411","article-title":"Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection","volume":"8","author":"Lok","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.healun.2006.03.002_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00007890-199703150-00026","article-title":"Risk of inappropriate exclusion of organ donors by introduction of hepatitis B core antibody testing","volume":"63","author":"Turner","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.03.002_bib9","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1128\/JCM.39.8.2937-2945.2001","article-title":"Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type I RNA","volume":"39","author":"Meng","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.healun.2006.03.002_bib10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1053-2498(01)00280-7","article-title":"Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area","volume":"20","author":"Ko","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1399-3062.2002.t01-1-01002.x","article-title":"Transmission of viral hepatitis by kidney transplantation","volume":"4","author":"Natov","year":"2002","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.healun.2006.03.002_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0016-5085(92)90851-O","article-title":"Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen","volume":"103","author":"McMahon","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.healun.2006.03.002_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-199501270-00014","article-title":"The risk of transmission of hepatitis B from HBsAg (\u2013), HBcAb (+), HBIgM (\u2013) organ donors","volume":"59","author":"Wachs","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.03.002_bib14","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/00007890-199712270-00027","article-title":"Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease","volume":"64","author":"Madayag","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.03.002_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00007890-199708150-00011","article-title":"Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors","volume":"64","author":"Satterthwaite","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.03.002_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.healun.2003.09.036","article-title":"Acceptable recipient outcomes with the use of hearts from donors with hepatitis B core antibodies","volume":"24","author":"Pinney","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/00365540050165866","article-title":"Levels of viremia in subjects with serological markers of past or chronic hepatitis B virus infection","volume":"32","author":"Noborg","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.healun.2006.03.002_bib18","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood-2002-03-0798","article-title":"Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen","volume":"100","author":"Hennig","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.healun.2006.03.002_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00007890-199908270-00013","article-title":"Can hepatits B core antibody positive livers be used safely for transplantation?","volume":"68","author":"Van Thiel","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.03.002_bib20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1537-2995.2004.04055.x","article-title":"Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc","volume":"44","author":"Kuhns","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.healun.2006.03.002_bib21","first-page":"49A","article-title":"Transmission of hepatitis B virus infection from orthotopic donor livers","volume":"16","author":"Douglas","year":"1992","journal-title":"Hepatology"},{"issue":"suppl 1","key":"10.1016\/j.healun.2006.03.002_bib22","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/320899","article-title":"Prophylactic measures in the solid-organ recipient before transplantation","volume":"33","author":"Avery","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2006.03.002_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(94)90934-2","article-title":"Hepatitis B virus as source of infection in liver transplant recipients","volume":"343","author":"Chazouilleres","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2006.03.002_bib24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1053-2498(01)00255-8","article-title":"HBV and HCV infections in heart transplant recipients","volume":"20","author":"Fagiuoli","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib25","first-page":"781","article-title":"A successful regimen for the prevention of seroconversion after transplantation of a heart positive for hepatitis B surface antigen","volume":"11","author":"Turik","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/gast.2000.17951","article-title":"Hepatitis virus infections in heart transplant recipients","volume":"119","author":"Lunel","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.healun.2006.03.002_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/00007890-199811270-00015","article-title":"Long-term outcome of chronic hepatitis B in heart transplant recipients","volume":"66","author":"Wedemeyer","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.03.002_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1053-2498(00)00142-X","article-title":"Outcomes in patients who are hepatitis B surface antigen-positive before transplantation","volume":"19","author":"Hosenpud","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib29","first-page":"327","article-title":"Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation","volume":"1","author":"Zheng","year":"2002","journal-title":"Hepatobil Pancreat Dis Int"},{"key":"10.1016\/j.healun.2006.03.002_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJM200301093480218","article-title":"Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus","volume":"348","author":"Benhamou","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2006.03.002_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/jhep.2000.8626","article-title":"Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants","volume":"32","author":"Perrillo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.healun.2006.03.002_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.TP.0000113466.53834.8A","article-title":"Favorable outcome of adefovir-dipivoxil treatment in acute de novo hepatitis B after liver transplantation","volume":"77","author":"Toniutto","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.03.002_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00001573-199803000-00009","article-title":"Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients","volume":"13","author":"Avery","year":"1998","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.healun.2006.03.002_bib34","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00007890-199911270-00013","article-title":"Famciclovir treatment of chronic hepatitis B in heart transplant recipients","volume":"68","author":"Wedemeyer","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.03.002_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/lt.20133","article-title":"Fibrosing cholestatic hepatitis secondary to precore\/core promoter hepatitis B variant with lamivudine resistance","volume":"10","author":"Lo","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-6143.2003.00063.x","article-title":"Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era","volume":"3","author":"Papatheodoridis","year":"2003","journal-title":"Am J Transplant"},{"unstructured":"Mawhorter S, Nasrallah M, Starling R, et al. Assessment of an accelerated hepatitis B vaccination protocol in congestive heart failure and left-ventricular assist device patients awaiting heart transplantation. Am J Transplant 2003(suppl 5):528.","key":"10.1016\/j.healun.2006.03.002_bib37"},{"key":"10.1016\/j.healun.2006.03.002_bib38","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1097\/00007890-200205270-00013","article-title":"Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis","volume":"73","author":"Joya-Vazquez","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.03.002_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1034\/j.1399-0012.2003.00119.x","article-title":"Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool","volume":"17","author":"Lopez-Navidad","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0168-8278(90)90226-H","article-title":"Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients","volume":"11","author":"Pol","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.healun.2006.03.002_bib41","first-page":"985","article-title":"Factors increasing the risk of allograft vascular disease in heart transplant recipients","volume":"27","author":"Arbustini","year":"1997","journal-title":"G Ital Cardiol"},{"key":"10.1016\/j.healun.2006.03.002_bib42","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1001\/jama.288.21.2724","article-title":"Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease","volume":"288","author":"Kalayoglu","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2006.03.002_bib43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3949\/ccjm.68.5.449","article-title":"Is atherosclerosis an infectious disease?","volume":"68","author":"Mawhorter","year":"2001","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.healun.2006.03.002_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.100.1.61","article-title":"Impact of prophylactic immediate post transplant ganciclovir on development of transplant atherosclerosis","volume":"100","author":"Valantine","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.03.002_bib45","first-page":"247","article-title":"Donor or recipient hepatitis B infection accelerates allograft vasculopathy","volume":"2","author":"Haji","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1034\/j.1600-6143.2002.20508.x","article-title":"Hepatitis C-positive donors in heart transplantation","volume":"2","author":"Marelli","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib47","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.510300519","article-title":"Outcome of de novo hepatitis C virus infection in heart transplant recipients","volume":"30","author":"Ong","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.healun.2006.03.002_bib48","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199209243271302","article-title":"Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs","volume":"327","author":"Pereira","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2006.03.002_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1399-3062.2002.02001.x","article-title":"A fatal case of hepatitis C seroconversion following living-related kidney transplantation","volume":"4","author":"Gordon","year":"2002","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.healun.2006.03.002_bib50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1053-2498(00)00062-0","article-title":"Hepatitis C transmission and infection by orthotopic heart transplantation","volume":"19","author":"Pfau","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1053-2498(00)00198-4","article-title":"Outcome of heart transplantation in patients previously infected with hepatitis C virus","volume":"20","author":"Minami","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib52","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7326\/0003-4819-143-9-200511010-00008","article-title":"Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor","volume":"143","author":"Tugwell","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2006.03.002_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-0012.1998.tb01061.x","article-title":"Hepatitis C status of heart transplant recipients","volume":"12","author":"Fagiuoli","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00003495-200464050-00003","article-title":"Treatment of hepatitis C in solid organ transplantation","volume":"64","author":"Chan","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.healun.2006.03.002_bib55","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/00041552-199311000-00009","article-title":"Hepatitis C in organ transplantation","volume":"2","author":"Pereira","year":"1993","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.healun.2006.03.002_bib56","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0041-1345(98)00583-1","article-title":"Combined human cytomegalovirus and hepatitis C virus infections increase the risk of allograft vascular disease in heart transplant recipients","volume":"30","author":"Dal Bello","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2006.03.002_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1053-2498(03)00148-7","article-title":"Donor hepatitis C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation","volume":"23","author":"Haji","year":"2004","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 2S","key":"10.1016\/j.healun.2006.03.002_bib58","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.healun.2004.11.130","article-title":"Outcomes with hepatitis C following cardiac transplantation","volume":"24","author":"Lake","year":"2005","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 1","key":"10.1016\/j.healun.2006.03.002_bib59","first-page":"S402","article-title":"Lymphoproliferative disorders in heart transplant recipients","volume":"13","author":"Fagiuoli","year":"2000","journal-title":"Transplant Int"},{"key":"10.1016\/j.healun.2006.03.002_bib60","first-page":"917","article-title":"Policies regarding the transplantation of hepatitis C-positive candidates and donor organs","volume":"16","author":"Lake","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.03.002_bib61","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/S0002-9270(02)04351-4","article-title":"Prevention of de novo hepatitis B infection in liver allograft recipients with previous hepatitis B infection or hepatitis B vaccination","volume":"97","author":"Barcena Marugan","year":"2002","journal-title":"Am J Gastroenterol"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324980600218X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324980600218X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:14:05Z","timestamp":1760948045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105324980600218X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S105324980600218X"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2006.03.002","relation":{},"ISSN":["1053-2498"],"issn-type":[{"type":"print","value":"1053-2498"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can Donors With Prior Hepatitis Be Safely Used for Heart Transplantation?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2006.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}